142 related articles for article (PubMed ID: 29554321)
21. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis.
Patel RA; Bell JB; Kim T; Agulnik M; Chandler JP; Mittal BB; Kruser TJ
J Neurooncol; 2017 Aug; 134(1):197-203. PubMed ID: 28547589
[TBL] [Abstract][Full Text] [Related]
23. Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity.
Cummings M; Youn P; Bergsma DP; Usuki KY; Walter K; Sharma M; Okunieff P; Schell MC; Milano MT
Neurosurgery; 2018 Sep; 83(3):437-444. PubMed ID: 28945885
[TBL] [Abstract][Full Text] [Related]
24. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
25. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
26. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
27. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
28. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
30. Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
Wolf A; Kvint S; Chachoua A; Pavlick A; Wilson M; Donahue B; Golfinos JG; Silverman J; Kondziolka D
J Neurosurg; 2018 Jan; 128(1):23-31. PubMed ID: 28298015
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors.
Elaimy AL; Mackay AR; Lamoreaux WT; Fairbanks RK; Demakas JJ; Cooke BS; Lee CM
World Neurosurg; 2011; 75(5-6):673-83. PubMed ID: 21704935
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
[TBL] [Abstract][Full Text] [Related]
34. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety and outcome of frameless image-guided robotic radiosurgery for brain metastases after whole brain radiotherapy.
Lohkamp LN; Vajkoczy P; Budach V; Kufeld M
J Neurooncol; 2018 May; 138(1):73-81. PubMed ID: 29376195
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
37. Fractionated stereotactic radiosurgery for locally recurrent brain metastases after failed stereotactic radiosurgery.
Dincoglan F; Sager O; Demiral S; Gamsiz H; Uysal B; Onal E; Ekmen A; Dirican B; Beyzadeoglu M
Indian J Cancer; 2019; 56(2):151-156. PubMed ID: 31062735
[TBL] [Abstract][Full Text] [Related]
38. The radiation oncologist's perspective on stereotactic radiosurgery.
Regine W
Technol Cancer Res Treat; 2002 Feb; 1(1):43-9. PubMed ID: 12614176
[TBL] [Abstract][Full Text] [Related]
39. Patient preference for stereotactic radiosurgery plus or minus whole brain radiotherapy for the treatment of brain metastases.
Zeng KL; Raman S; Sahgal A; Soliman H; Tsao M; Wendzicki C; Chow E; Lo SS
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S155-S160. PubMed ID: 28866900
[TBL] [Abstract][Full Text] [Related]
40. Prospective comparison of volumetric post-contrast T1-Sampling Perfection with Application optimized Contrasts by using different flip angle Evolutions and Magnetization-Prepared Rapid Acquisition with Gradient Echo in patients with metastatic melanoma.
Lasocki A; Caspersz L; McArthur GA
Neuroradiol J; 2023 Apr; 36(2):169-175. PubMed ID: 35815337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]